
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Anissa Boumlic, PHD, is associate director EMEA vaccine and viral therapies, MilliporeSigma.
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Published: September 1st 2018 | Updated: